The activity is consistent with routine option exercise and tax-related or planned sales rather than negative sentiment; monitor for further sales or commentary in upcoming filings. No material financial impact expected.
Price Chart
Executive Summary
United Therapeutics insiders, including CEO Martine Rothblatt and CFO James Edgemond, conducted a series of derivative exercises and open-market sales over the past week. The total open-market sales amounted to approximately $1.07 million, with the majority tied to option exercises at low strike prices, indicating planned equity realization rather than reactive selling.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 559 shares for $373,765 across multiple transactions at prices between $516.84 and $536.97.
- CFO James Edgemond sold 991 shares for $527,236; also exercised 20,000 derivative shares (10,000 at $135.42, 10,000 at $0).
- Director Tommy Thompson sold 275 shares for $147,845 and exercised 4,000 derivative shares.
- Director Judy Olian sold 200 shares for $106,000.
- Total open-market sales: $1,073,360; total derivative exercises: over $5.7 million in non-cash transactions.
- All sales represent a tiny fraction (0.0046%) of United Therapeutics' $23.3B market cap.
Financial Impact
$1.07 million in open-market sales and over $5.7 million in derivative exercises over 7 days
Risk Factors
- Perception of insider selling could weigh on sentiment if misinterpreted.
- Future sales could increase if insiders continue exercising options.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-UTHR-1774643538723 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access